ReviewExperimental & molecular medicine2024

Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2.

Yunju Jo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.